Tilray Brands Inc
General ticker "TLRY" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.1B
Tilray Brands Inc does not follow the US Stock Market performance with the rate: -27.2%.
Estimated limits based on current volatility of 5.2%: low 1.21$, high 1.34$
Factors to consider:
- North America accounted for 51.8% of revenue in the fiscal year ended 2023-05-31
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-05-31 to 2026-05-31
- 2024-05-31 to 2025-05-31 estimated range: [1.27$, 2.49$]
- 2025-05-31 to 2026-05-31 estimated range: [1.43$, 2.72$]
Financial Metrics affecting the TLRY estimates:
- Negative: Non-GAAP EPS, $ of -0.31 <= 0.10
- Negative: Operating profit margin, % of -18.13 <= 1.03
- Negative: Operating cash flow per share per price, % of -2.05 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0.07 <= 0.14
Short-term TLRY quotes
Long-term TLRY plot with estimates
Financial data
YTD | 2023-05-31 | 2024-05-31 |
---|---|---|
Operating Revenue | $627.12MM | $788.94MM |
Operating Expenses | $1,996.81MM | $963.69MM |
Operating Income | $-1,369.68MM | $-174.75MM |
Non-Operating Income | $-80.50MM | $-74.28MM |
Interest Expense | $13.59MM | $49.26MM |
R&D Expense | $0.68MM | $0.64MM |
Income(Loss) | $-1,450.18MM | $-249.02MM |
Taxes | $-7.18MM | $-26.62MM |
Profit(Loss) | $-1,443.00MM | $-222.40MM |
Stockholders Equity | $3,315.69MM | $3,442.91MM |
Inventory | $200.55MM | $252.09MM |
Assets | $4,307.26MM | $4,221.66MM |
Operating Cash Flow | $7.91MM | $-30.91MM |
Capital expenditure | $20.80MM | $29.25MM |
Investing Cash Flow | $-285.11MM | $128.35MM |
Financing Cash Flow | $70.16MM | $-75.19MM |
Earnings Per Share* | $-2.34 | $-0.33 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.